Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gatifloxacin 0.3% eye drops
1103010AKAAAAAA
|
Gatifloxacin | Gatifloxacin | Eye | No data available |
|
Gauze wound dressing 15cm x 17cm
20032500026
|
Gauze wound dressing 15cm x 17cm | Wound Management & Other Dressings | Dressings | No data available |
|
Gavilast Heartburn and Indigestion 75mg tablets
0103010T0BUABAP
|
Gavilast | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Gavilast-P 75mg tablets
0103010T0BTAAAP
|
Gavilast-P | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Gaviscon 500mg chewable tablets lemon
0101021B0BEAHAG
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Gaviscon Extra Strength chewable tablets lemon
0101021B0BEALAG
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Gaviscon Instants Tropical Fruit Flavour oral powder sachets
0101021B0BEAXA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Gaviscon Lemon chewable tablets
0101021B0BEATAR
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Gazyvaro 1000mg/40ml concentrate for inf vials
0802030G0BBAAAA
|
Gazyvaro | Obinutuzumab | Malignant Disease and Immunosuppression | No data available |
|
GBUK gellhorn pessary size 1, 45mm diameter, silicone, standard stem
21011200410
|
GBUK gellhorn pessary size 1, 45mm diameter, silicone, standard stem | Other Appliances | Appliances | No data available |
|
GBUK ring pessary size 8, 95mm diameter, silicone without support
21011200408
|
GBUK ring pessary size 8, 95mm diameter, silicone without support | Other Appliances | Appliances | No data available |
|
Gefitinib 250mg tablets
0801050AWAAAAAA
|
Gefitinib | Gefitinib | Malignant Disease and Immunosuppression | No data available |
|
Gel FX sheet 10cm x 10cm square
20031200060
|
Gel FX sheet 10cm x 10cm square | Wound Management & Other Dressings | Dressings | No data available |
|
Gel FX sheet 10cm x 15cm rectangular
20031200062
|
Gel FX sheet 10cm x 15cm rectangular | Wound Management & Other Dressings | Dressings | No data available |
|
Gel FX sheet 15cm x 15cm square
20031200061
|
Gel FX sheet 15cm x 15cm square | Wound Management & Other Dressings | Dressings | No data available |
|
Gelaspan 4% infusion 1litre Ecobags
0902022I0BFABAC
|
Gelaspan | Gelatin | Nutrition and Blood | No data available |
|
Gelatin 4% infusion 1litre bags
0902022I0AAACAC
|
Gelatin | Gelatin | Nutrition and Blood | No data available |
|
Gelatin 4% infusion 500ml bags
0902022I0AAAAAA
|
Gelatin | Gelatin | Nutrition and Blood | No data available |
|
Gelcotar liquid
1309000C0BBAAAA
|
Gelcotar (Scalp) | Coal tar | Skin | No data available |
|
Geliperm sheet 10cm x 10cm square
20031200033
|
Geliperm sheet 10cm x 10cm square | Wound Management & Other Dressings | Dressings | No data available |
|
Gelofusine 4% infusion 1litre Ecobags
0902022I0BBACAC
|
Gelofusine | Gelatin | Nutrition and Blood | No data available |
|
Gelofusine 4% infusion 500ml Ecobags
0902022I0BBABAA
|
Gelofusine | Gelatin | Nutrition and Blood | No data available |
|
Gemcitabine 1.5g powder for solution for infusion vials
0801030X0AAACAC
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g powder for solution for infusion vials
0801030X0AAAAAA
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
|
Gemcitabine 1g/10ml solution for infusion vials
0801030X0AAAIAI
|
Gemcitabine | Gemcitabine | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.